OrthAlign has expanded its Lantern hip platform to support posterior-based approaches in total hip arthroplasty, broadening the handheld navigation system’s use across all patient positions. The ...

New software broadens market reach and enables surgeons to use Lantern Hip with their preferred surgical approach, including ...

Sustained long-term safety data for tildrakizumab strengthens the positioning of IL-23 inhibitors as a preferred choice, ...

Our policy position is centred around the need to advocate for equitable access to healthcare, create safe and inclusive workplaces for trans and non-binary people working in healthcare settings, and ...

The combination of Keytruda and Padcev is taking another major step toward securing its position as a leading therapy in the ...

Liver disease is a major global health problem, causing over two million deaths worldwide each year. While animal models have ...

The Minnesota Wild acquired Hughes in exchange for Marco Rossi, Zeev Buium, Liam Ohgren, and a 2026 first-round pick to ...

Explore Veru's Q4 2025 earnings, strategic shift to drug development, regulatory clarity, and new trials for obesity management.

Funds that will succeed are those that will adapt their strategy including tighter discipline on achieving exits within ...

Arcellx (ACLX) is positioned to disrupt multiple myeloma cell therapy with anito-cel, leveraging superior efficacy, safety, ...

Whether you are heading to bed or seeking a midnight snack, you don't need to turn on the lights to know where you are as you ...